OBZEO Trademark

Trademark Overview

On Thursday, February 20, 2025, a trademark application was filed for OBZEO with the United States Patent and Trademark Office. The USPTO has given the OBZEO trademark a serial number of 99048593. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, July 30, 2025. This trademark is owned by Zenas BioPharma, Inc.. The OBZEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system
obzeo

General Information

Serial Number99048593
Word MarkOBZEO
Filing DateThursday, February 20, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, July 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZenas BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Thursday, February 20, 2025NEW APPLICATION ENTERED
Thursday, February 20, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 20, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 25, 2025ASSIGNED TO EXAMINER
Wednesday, July 30, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 30, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

obzeo diseases pharmaceutical preparations biological autoimmune inflammatory immunoglobulin related disease multiple